Johnson & Johnson — Press Releases Health Press Releases — RSS Feed & Live Monitoring
PPN World tracks the Johnson & Johnson — Press Releases RSS feed in real time — 8 releases indexed over the last 30 days, the newest arrived 3 d ago. Follow it with saved-search alerts, AI summaries, and full-text search, or plug the RSS URL below into your own reader.
Johnson & Johnson — Press Releases RSS feed URL
https://investor.jnj.com/rss/pressrelease.aspxAbout this feed
Johnson & Johnson — Press Releases is one of the 1000+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed under United States in our country index. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. Over the last 30 days Johnson & Johnson — Press Releases has published 8 releases, busiest on Wednesdays.
How to follow Johnson & Johnson — Press Releases press releases
- Copy the Johnson & Johnson — Press Releases RSS feed URL shown above.
- Paste it into any RSS reader (Feedly, Inoreader, NetNewsWire…) to get the raw feed.
- Or track Johnson & Johnson — Press Releases in PPN World to add deduplication, saved-search alerts, and AI summaries across all 1000+ wires.
Latest Johnson & Johnson — Press Releases press releases
- Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System3 d ago
- Johnson & Johnson Announces Collaboration with TIME to Introduce New Healthcare Champion of the Year Award9 d ago
- Johnson & Johnson Announces Quarterly Dividend for Third Quarter 202610 d ago
- Johnson & Johnson reports Q2 2026 results, raises 2026 outlook10 d ago
- Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform17 d ago
- DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer25 d ago
- Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis29 d ago
- CHMP recommendation advances Johnson & Johnson’s TECVAYLI®▼ (teclistamab) plus daratumumab as a potential standard of care for relapsed/refractory multiple myeloma29 d ago
- Johnson & Johnson Invests more than $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Florida40 d ago
The newest releases on this wire stream live for PPN World members.